Medical News

RSS

View News A-Z »

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

A new study describes mutations found in the SARS-CoV-2 BA.1 variant in Hong Kong and New Zealand.

20 Mar 2022

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

Researchers provide insight on the potentially significant impact of aerosol pH on the transmission of SARS-CoV-2.

20 Mar 2022

UT Dallas researchers explore origins of chronic pain and the potential for better treatments

An investigation into how human nerve cells differ from animal cells has provided researchers from The University of Texas at Dallas' Center for Advanced Pain Studies with important clues in the pursuit of more effective treatments for chronic pain.

19 Mar 2022

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group NRG Oncology, NRG-GY017, concluded that the addition of the immunotherapy drug atezolizumab prior to and concurrently given with chemoradiation (CRT) treatment was safe for women with node-positive, locally advanced cervical cancer.

19 Mar 2022

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Results of a biomarker analysis of the NRG Oncology NRG-GY004 trial were presented at a Seminal Session during the Society for Gynecologic Oncology's (SGO) Annual Meeting on Women's Cancer in March 2022.

19 Mar 2022

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show.

19 Mar 2022

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year compared to 94% of those with chest pain as the predominant feature.

19 Mar 2022

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology.

19 Mar 2022

Expert reveals why brain science should be embraced in Sub-Saharan Africa

Medical conditions that affect the brain and the nerves in the human body — called neurological disorders — contribute greatly to the global burden of diseases, but even more so in low- and middle-income countries.

19 Mar 2022

Study provides new understanding of how memory works when the brain sees a familiar face

In a study led by Cedars-Sinai, researchers have uncovered new information about how the area of the brain responsible for memory is triggered when the eyes come to rest on a face versus another object or image.

18 Mar 2022

Reactivating Piezo1 protein could help repair broken down, dystrophic muscles

One protein, Piezo1, is key to marshalling muscle stem cells' unique shapes and response to injuries, but it is in low supply in those with Duchenne muscular dystrophy, according to a team at the Perelman School of Medicine at the University of Pennsylvania.

18 Mar 2022

NYU Long Island School Of Medicine's Class of 2022 discover their "doctor destinies" on Match Day

On Friday, March 18, NYU Long Island School of Medicine held its first Match Day, a ceremony that takes place at medical schools across the nation during which it is revealed where graduating students will fulfill their medical residencies.

18 Mar 2022

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.

18 Mar 2022

Understanding how coronavirus, RS virus and rhinovirus affect children

When Inger Heimdal started studying the coronavirus in children in 2014, not many people thought the topic sounded particularly exciting.

18 Mar 2022

Study: Targeting astrocytes reduces tau-related brain damage and inflammation in mice

Alzheimer's disease is the most common and best known of the tauopathies, a set of neurodegenerative brain diseases caused by toxic tangles of the protein tau.

18 Mar 2022

Study finds significantly poorer outcomes among the youngest patients with brain tumor

A University of Colorado Cancer Center researcher has found, through extensive data analysis, that the youngest patients with brain tumors – those ages birth to 3 months – have about half the five-year survival rate as children ages 1 to 19.

18 Mar 2022

Deactivation of specific brain cells makes mice more resilient against chronic stress

It is well known that long-term exposure to stress can lead to serious psychiatric problems. However, the precise mechanisms underpinning the stress response have remained largely elusive.

18 Mar 2022

New study tracks food insecurity during the COVID-19 pandemic

In response to the rapid spread of COVID‐19, governments across the globe implemented local lockdowns that led to increased unemployment and disrupted local and international transport routes and supply chains.

18 Mar 2022

Researchers explore experiences with compulsive exercise across social media

Compulsive exercise (CE) gets little attention, despite being a fairly common and serious condition. There is no universally recognized definition of compulsive exercise, though it involves being obsessed and all-consumed by exercising, and those who suffer from it often describe themselves as being miserable, in pain, or depressed all the time.

18 Mar 2022

Researchers find ketamine to have significant anti-depressant and anti-suicidal effects

First manufactured more than 50 years ago, ketamine is a fast-acting dissociative anesthetic often used in veterinary and emergency medicine. Ketamine also has a history of being an illicit party drug.

18 Mar 2022

Medical News

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Acidity of expiratory aerosols influences infectivity of SARS-CoV-2

UT Dallas researchers explore origins of chronic pain and the potential for better treatments

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

HRR mutational status associated with survival outcomes in recurrent platinum-sensitive ovarian cancer

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Expert reveals why brain science should be embraced in Sub-Saharan Africa

Study provides new understanding of how memory works when the brain sees a familiar face

Reactivating Piezo1 protein could help repair broken down, dystrophic muscles

NYU Long Island School Of Medicine's Class of 2022 discover their "doctor destinies" on Match Day

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Understanding how coronavirus, RS virus and rhinovirus affect children

Study: Targeting astrocytes reduces tau-related brain damage and inflammation in mice

Study finds significantly poorer outcomes among the youngest patients with brain tumor

Deactivation of specific brain cells makes mice more resilient against chronic stress

New study tracks food insecurity during the COVID-19 pandemic

Researchers explore experiences with compulsive exercise across social media

Researchers find ketamine to have significant anti-depressant and anti-suicidal effects

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News